Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
Launched by NORTHWELL HEALTH · Jun 28, 2019
Trial Information
Current as of June 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the treatment for people experiencing their first episode of psychosis, which can include symptoms like hallucinations or delusions. The goal is to create a network that learns from real-life experiences to enhance care and outcomes for these patients. If you or someone you know is between the ages of 18 and 45 and is currently enrolled in a Coordinated Specialty Care (CSC) program for first episode psychosis, you might be eligible to participate in this study.
Participants in this trial will be part of a research effort that aims to gather valuable information to help improve treatment approaches. There are no specific exclusions for this trial, meaning that if you're enrolled in the CSC program, you can join. As the study is currently recruiting participants, this is a great opportunity to contribute to research that could benefit others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrolled in CSC program
- Exclusion Criteria:
- • none
About Northwell Health
Northwell Health is a leading integrated health system based in New York, dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to improving patient outcomes and enhancing medical knowledge, Northwell Health conducts a diverse range of clinical studies across various therapeutic areas. The organization harnesses its extensive network of hospitals, outpatient facilities, and research institutes to facilitate cutting-edge research, ensuring access to advanced treatments for patients while fostering collaboration among healthcare professionals, researchers, and industry partners. By prioritizing patient-centric approaches and leveraging state-of-the-art technology, Northwell Health aims to drive significant advancements in medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lauderdale Lakes, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials